Foreign Filer Report • Aug 28, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
August 28, 2025
Commission File Number 001-36761
1 Temasek Avenue #37-02B Millenia Tower Singapore 039192 (Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBITS 99.1 AND 99.2 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-201716) OF KENON HOLDINGS LTD. AND IN THE PROSPECTUSES RELATING TO SUCH REGISTRATION STATEMENT.
99.1 Press Release, dated August 28, 2025: Kenon Holdings Reports Q2 2025 Results and Additional Updates 99.2 Q2 2025 Summary Financial Information of Kenon and OPC and Reconciliation of Certain non-IFRS Financial Information
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
KENON HOLDINGS LTD.
| Date: August 28, 2025 | By: | /s/ Robert L. Rosen |
|---|---|---|
| Name: | Robert L. Rosen | |
| Title: | Chief Executive Officer | |

Singapore, August 28, 2025. Kenon Holdings Ltd. (NYSE: KEN, TASE: KEN) ("Kenon") announces its results for Q2 2025 and additional updates.
OPC
1 Adjusted EBITDA including proportionate share in associated companies is a non-IFRS measure. See Exhibit 99.2 of Kenon's Form 6-K dated August 28, 2025 for the definition of OPC's EBITDA and Adjusted EBITDA including proportionate share in associated companies and a reconciliation to profit for the applicable period.
Kenon's consolidated results of operations essentially comprise the consolidated results of OPC Energy Ltd ("OPC").
See Exhibit 99.2 of Kenon's Form 6-K dated August 28, 2025 for a summary of Kenon's consolidated financial information; a summary of OPC's consolidated financial information; a reconciliation of OPC's EBITDA and Adjusted EBITDA including proportionate share in associated companies (which is a non-IFRS measure) to profit for the period; a summary of financial information of OPC's subsidiaries.
The following discussion of OPC's results of operations is derived from OPC's consolidated financial statements, which are denominated in NIS for purposes of OPC's financial statements, as translated into US dollars for Kenon's financial statements.
| For the three months ended June 302, |
|||
|---|---|---|---|
| 2025 | 2024 | ||
| \$ millions | |||
| Revenue | 196 | 181 | |
| Cost of sales (excluding depreciation and amortization) | (150) | (129) | |
| Finance expenses, net | (20) | (23) | |
| Share in profit of associated companies, net | 21 | 4 | |
| Profit for the period | 1 | (7) | |
| Attributable to: | |||
| Equity holders of OPC | 1 | (4) | |
| Non-controlling interest | - | (3) | |
| Adjusted EBITDA including proportionate share in associated companies3 | 90 | 66 |
For a summary of OPC's results please refer to Appendix B.
Set forth below is a summary of OPC's revenue in Israel and the U.S. for the three months ended June 30, 2025 ("Q2 2025") and 2024 ("Q2 2024").
| For the three months ended June 30, |
||
|---|---|---|
| 2025 | 2024 | |
| \$ millions | ||
| Israel | 153 | 146 |
| U.S. | 43 | 35 |
| Total | 196 | 181 |
•
OPC's revenue increased by \$15 million in Q2 2025 as compared to Q2 2024. Excluding the impact of translating OPC's revenue from NIS to USD4, OPC's revenue increased by \$8 million in Q2 2025 as compared to Q2 2024.
2 The tables herein translate OPC's NIS results into US\$ at the average exchange rate for the relevant period.
3 Non-IFRS measure. See Exhibit 99.2 of Kenon's Form 6-K dated August 28, 2025 for the definition of OPC's EBITDA and Adjusted EBITDA including proportionate share in associated companies and a reconciliation to profit for the applicable period.
4 The OPC Q2 2025 results presented herein and the corresponding comparative figures in Q2 2024 discussed herein were converted using an average exchange rate of \$0.278/NIS.
Set forth below is a discussion of significant changes in revenue between Q2 2025 and Q2 2024.
Set forth below is a summary of OPC's cost of sales (excluding depreciation and amortization) in Israel and the U.S. for the three months ended June 30, 2025 and 2024.
| For the three months ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| \$ millions | ||
| Israel | 114 | 110 |
| U.S. | 36 | 19 |
| Total | 150 | 129 |
OPC's cost of sales (excluding depreciation and amortization) increased by \$21 million from Q2 2024 to 2025. Excluding the impact of translating OPC's cost of sales (excluding depreciation and amortization) from NIS to USD5, OPC's cost of sales (excluding depreciation and amortization) increased by \$16 million in Q2 2025 as compared to Q2 2024. Set forth below is a discussion of significant changes in cost of sales between Q2 2025 and Q2 2024.
Israel
• Expenses in respect of infrastructure services in Israel – Increased by \$9 million in Q2 2025 as compared to Q2 2024. Excluding the impact of translating OPC's cost of sales (excluding depreciation and amortization) from NIS to USD, such costs increased by \$8 million primarily as a result of higher average tariffs in Q2 2025;
5 The OPC Q2 2025 results presented herein and the corresponding comparative figures in Q2 2024 discussed herein were converted using an average exchange rate of \$0.278/NIS.

• Expenses for natural gas and diesel oil in Israel – Decreased by \$3 million in Q2 2025 as compared to Q2 2024. Excluding the impact of translating OPC's cost of sales (excluding depreciation and amortization) from NIS to USD, such costs decreased by \$4 million primarily as a result of lower customer consumption in Q2 2025 due to a decrease in the sales of Tzomet to the system operator in Q2 2025; and
• Other expenses in Israel – Decreased by \$4 million in Q2 2025 as compared to Q2 2024 primarily as a result of the deconsolidation of Gnrgy at the end of Q2 2024.
Finance expenses, net in Q2 2025 were \$20 million, as compared to \$23 million in Q2 2024.
OPC's share of profit of associated companies, net increased by \$17 million in Q2 2025 as compared in Q2 2024, primarily as a result of an increase in OPC's ownership stakes in CPV Shore and CPV Maryland in Q4 2024 and Q2 2025.
For further details of the results of certain associated companies of CPV, refer to OPC's immediate report published on the Tel Aviv Stock Exchange ("TASE") on August 13, 2025 and the convenience English translations furnished by Kenon on Form 6-K with the U.S. Securities and Exchange Commission on August 13, 2025.
As of June 30, 2025, OPC had unrestricted cash and cash equivalents of \$470 million, restricted cash of \$17 million (including restricted cash used for debt service), and total outstanding consolidated indebtedness of \$1,403 million, consisting of \$101 million of short-term indebtedness and \$1,302 million of long-term indebtedness. As of June 30, 2025, a substantial portion of OPC's debt was denominated in NIS.
As of June 30, 2025, OPC's proportionate share of debt (including accrued interest) of associated companies of CPV was \$1,149 million and its proportionate share of cash and cash equivalents was \$92 million.
In June 2025, OPC raised gross proceeds of NIS 850 million (\$240 million) by issuing 21,313,000 ordinary shares. OPC reported that it intends to use a portion of the proceeds of the offering for part of the CPV Group's share in the equity required for the construction of the Basin Ranch project, if that project proceeds, and/or for other purposes as may be determined by OPC.
Kenon purchased 7,923,600 ordinary shares in the offering for approximately NIS 316 million (\$90 million).
In August 2025, OPC issued 18,750,000 ordinary shares to institutional investors in a private placement in Israel for gross proceeds of NIS 900 million (\$266 million).
OPC reported that it intends to use the proceeds of the private placement for the continued growth and development of OPC's businesses and/or for OPC's needs, as determined by OPC's board of directors from time to time.
Following completion of these offerings described above, Kenon now holds approximately 49.8% of OPC's shares.
In August 2025, the Israeli Government approved the plan to construct a natural gas-fired power plant ("Hadera 2") on land owned near OPC's Hadera power plant (the "Hadera 2 Plan"). OPC announced that it is preparing for the construction of Hadera 2 with an estimated capacity of approximately 850 MW (the "Hadera 2 Project") and it has preliminarily assessed the cost of construction of the Hadera 2 Project would be approximately NIS 4.5 billion to NIS 5 billion (approximately \$1.3 billion to \$1.5 billion).
In August 2025, OPC announced that its board of directors approved a partial early redemption of approximately NIS 256 million (approximately \$75 million) par value of its Series B Bonds, to be completed on September 30, 2025, at the par value of the bonds together with a payment in accordance with the Series B Bonds indenture of approximately NIS 48 million (approximately \$14 million). Following this early redemption, the outstanding par value of the Series B Bonds balance is expected to decrease to approximately NIS 440 million (approximately \$129 million) par value.
As of June 30, 2025 and August 28, 2025, Kenon's stand-alone cash was approximately \$560 million. There is no material debt at the Kenon level.
Kenon's stand-alone cash includes cash and cash equivalents and other treasury management instruments.
Since March 2023, Kenon has repurchased approximately 1.8 million shares for total consideration of approximately \$48 million under its repurchase plan. Kenon has approximately 52 million outstanding shares after giving effect to these repurchases.
In August 2025, Kenon's board has increased the authorized share repurchase plan by \$10 million to up to \$70 million in total (including shares already purchased under the plan). Furthermore, Kenon has entered into an additional mandate for repurchases under the plan of up to \$20 million through open market purchases on the TASE only, subject to certain conditions, including price levels which are currently not met. The mandate will expire on March 31, 2026.
The share repurchase plan may be suspended or modified and may not be completed in full. Also, the mandate, which is irrevocable, may not be completed in full or in part as purchases of shares thereunder are subject to meeting conditions, including as to price levels, which cannot be altered.
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can generally identify these statements by the use of words like "may", "will", "could", "should", "believe", "expect", "plan", "estimate", "forecast", "potential", "intend", "target", "future", and variations of these words or comparable words. These statements include statements relating to OPC, including equity offerings by OPC and OPC's indications of its intended use of proceeds, government approval of the Hadera 2 Plan, the Hadera 2 Project and OPC's statements about its preparation for construction of the Hadera 2 Project, the estimated capacity and construction cost of the Hadera 2 Project, statements about OPC's partial redemption of its Series B Bonds, Kenon's share repurchase plan including the increase in the size of the plan and the repurchase mandate announced in this release including the conditions thereto and other non-historical matters. These statements are based on current expectations or beliefs and are subject to uncertainty and changes in circumstances. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond Kenon's control, which could cause the actual results to differ materially from those indicated in such forward-looking statements. Such risks include risks relating to the use of proceeds of the OPC offerings described herein, including the risk that the Basin Ranch project does not proceed on the terms described herein or previously announced terms or at all, risks relating to government approval of the Hadera 2 Plan, including risks relating to any published government decision relating to the Hadera 2 Plan if and when published, risks relating to the Hadera 2 Project, including the ultimate cost and characteristics of the Hadera 2 Project (including capacity), risks as to whether the Hadera 2 Project proceeds and is completed, risks relating to Kenon's share repurchase plan and the mandate announced in this release including risks relating to conditions of the mandate and the amount of shares that will actually be repurchased under the share repurchase program, and the mandate announced in this release and other risks and factors including those risks set forth under the heading "Risk Factors" in Kenon's most recent Annual Report on Form 20-F filed with the SEC and other filings. Except as required by law, Kenon undertakes no obligation to update these forward-looking statements, whether as a result of new information, future events, or otherwise.
Kenon Holdings Ltd. Deepa Joseph Chief Financial Officer [email protected]

Reconciliation of Certain non-IFRS Financial Information
Appendix A: Summary of Kenon's consolidated financial information
Appendix B: Summary of OPC's consolidated financial information
Appendix C: Definition of OPC's Adjusted EBITDA and non-IFRS reconciliation
Summary Kenon consolidated financial information
| June 30, | December 31, | ||
|---|---|---|---|
| 2025 | 2024 | ||
| Current assets | \$ millions | ||
| Cash and cash equivalents | 915 | 1,016 | |
| Trade receivables | 121 | 80 | |
| Short-term derivative instruments | 8 | - | |
| Other investments | 115 | 143 | |
| Other current assets | 22 | 24 | |
| Total current assets | 1,181 | 1,263 | |
| Non-current assets | |||
| Investment in OPC's associated companies | 1,569 | 1,459 | |
| Long-term restricted cash | 16 | 16 | |
| Long-term derivative instruments | 14 | 28 | |
| Deferred taxes, net | 2 | 3 | |
| Property, plant and equipment, net | 1,239 | 1,156 | |
| Intangible assets, net | 79 | 72 | |
| Long-term prepaid expenses and other non-current assets | 43 | 41 | |
| Right-of-use assets, net | 193 | 175 | |
| Total non-current assets | 3,155 | 2,950 | |
| Total assets | 4,336 | 4,213 | |
| Current liabilities | |||
| Current maturities of loans from banks and others | 101 | 85 | |
| Trade and other payables | 169 | 94 | |
| Current maturities of lease liabilities | 3 | 4 | |
| Total current liabilities | 273 | 183 | |
| Non-current liabilities | |||
| Long-term loans from banks and others | 844 | 727 | |
| Debentures | 459 | 456 | |
| Deferred taxes, net | 150 | 148 | |
| Other non-current liabilities | 6 | 31 | |
| Long-term lease liabilities | 8 | 9 | |
| Total non-current liabilities | 1,467 | 1,371 | |
| Total liabilities | 1,740 | 1,554 | |
| Equity | |||
| Share capital | 50 | 50 | |
| Translation reserve | 17 | 3 | |
| Capital reserve | 57 | 64 | |
| Accumulated profit | 1,265 | 1,491 | |
| Equity attributable to owners of the Company | 1,389 | 1,608 | |
| Non-controlling interests | 1,207 | 1,051 | |
| Total equity | 2,596 | 2,659 | |
| Total liabilities and equity | 4,336 | 4,213 | |
| ended June 30, | For the six months | For the three months | ||
|---|---|---|---|---|
| 2025 | 2024 | ended June 30, 2025 |
2024 | |
| \$ millions | \$ millions | |||
| Revenue | 378 | 355 | 196 | 181 |
| Cost of sales and services (excluding depreciation and amortization) | (289) | (247) | (150) | (129) |
| Depreciation and amortization | (33) | (42) | (17) | (22) |
| Gross profit | 56 | 66 | 29 | 30 |
| Selling, general and administrative expenses | (48) | (43) | (31) | (22) |
| Other expenses, net | (1) | (7) | - | 1 |
| Operating profit/(loss) | 7 | 16 | (2) | 9 |
| Financing expenses | (45) | (51) | (21) | (31) |
| Financing income | 22 | 20 | 9 | 8 |
| Financing expenses, net | (23) | (31) | (12) | (23) |
| Gains related to ZIM | - | 111 | - | 111 |
| Dividend income | - | 6 | - | 6 |
| Share in profit of OPC's associated companies, net | 59 | 23 | 21 | 4 |
| Profit before income taxes | 43 | 125 | 7 | 107 |
| Income tax expense | (10) | (8) | (1) | - |
| Profit for the year | 33 | 117 | 6 | 107 |
| Attributable to: | ||||
| Kenon's shareholders | 17 | 121 | 5 | 112 |
| Non-controlling interests | 16 | (4) | 1 | (5) |
| Profit for the period | 33 | 117 | 6 | 107 |
| Basic/diluted profit per share attributable to Kenon's shareholders (in dollars): | ||||
| Basic/diluted profit per share | 0.32 | 2.28 | 0.10 | 2.13 |
| For the six months ended June 30, |
|||
|---|---|---|---|
| 2025 | 2024 | ||
| \$ millions | |||
| Cash flows from operating activities | |||
| Profit for the period | 33 | 117 | |
| Adjustments: | |||
| Depreciation and amortization | 36 | 44 | |
| Diesel fuel consumption | 5 | 2 | |
| Financing expenses, net | 23 | 31 | |
| Gains related to ZIM | - | (111) | |
| Share in profit of associated companies, net | (59) | (23) | |
| Share-based payments | 11 | 3 | |
| Other expenses, net | 1 | 8 | |
| Income tax expense | 10 | 8 | |
| 60 | 79 | ||
| Change in trade and other receivables | (37) | (28) | |
| Change in trade and other payables | 31 | 24 | |
| Cash generated from operating activities | 54 | 75 | |
| Income tax paid | - | (1) | |
| Dividends received from associate companies, net | 27 | 13 | |
| Net cash provided by operating activities | 81 | 87 | |
| 2025 2024 \$ millions Cash flows from investing activities Short-term deposits and restricted cash, net - Short-term collaterals deposits, net - 2 Investment in long-term deposit, net 2 1 Investment in associated companies, less cash acquired (110) Acquisition of property, plant and equipment (38) Proceed from sale of interest in ZIM - 111 Proceed from distribution from associated company 1 - Proceeds from other investments 31 56 Interest received 18 13 Proceeds from transactions in derivatives, net 5 - Net cash (used in)/provided by investing activities (91) 37 Cash flows from financing activities Repayment of long-term loans, debentures and lease liabilities (56) Repayment of short-term loans (1) Investments of non-controlling interests in subsidiary 10 9 Tax equity investment - 41 Proceeds from issuance of share capital 143 - Proceeds from issuance of debentures, less issuance expenses - 52 Proceeds from long-term loans 88 16 Proceeds from derivative financial instruments, net 5 1 Dividend paid (253) Repurchased of own shares (10) - Interest paid (25) Net cash used in financing activities (99) Decrease in cash and cash equivalents (109) Cash and cash equivalents at beginning of the year 1,016 697 Effect of exchange rate fluctuations on balances of cash and cash equivalents 8 Cash and cash equivalents at end of the period 915 586 |
For the six months ended June 30, |
||
|---|---|---|---|
| (1) (8) (137) (66) (55) (201) (31) (234) (110) (1) |
|||
Information regarding activities of the reportable segments are set forth in the following table.
| For the six months ended June 30, 2025 | ||||
|---|---|---|---|---|
| OPC Israel | CPV Group | Other | Consolidated Results | |
| \$ millions | ||||
| Revenue | 299 | 79 | - | 378 |
| Depreciation and amortization | (36) | - | - | (36) |
| Financing income | 3 | 3 | 16 | 22 |
| Financing expenses | (19) | (20) | (6) | (45) |
| Share in profit of associated companies | - | 59 | - | 59 |
| Profit before taxes | 17 | 17 | 9 | 43 |
| Income tax (expense)/benefits | (9) | 2 | (3) | (10) |
| Profit for the period | 8 | 19 | 6 | 33 |
| For the six months ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM | Other | Consolidated Results | |
| \$ millions | |||||
| Revenue | 291 | 64 | - | - | 355 |
| Depreciation and amortization | (33) | (13) | - | - | (46) |
| Financing income | 4 | 2 | - | 14 | 20 |
| Financing expenses | (32) | (15) | - | (4) | (51) |
| Gains related to ZIM | - | - | 111 | - | 111 |
| Share in profit of associated companies | - | 23 | - | - | 23 |
| Profit before taxes | 3 | 1 | 111 | 10 | 125 |
| Income tax expense | (7) | - | - | (1) | (8) |
| (Loss)/profit for the period | (4) | 1 | 111 | 9 | 117 |
| For the three months ended June 30, 2025 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | Other | Consolidated Results | ||
| \$ millions | |||||
| Revenue | 153 | 43 | - | 196 | |
| Depreciation and amortization | (18) | - | - | (18) | |
| Financing income | 1 | 2 | 6 | 9 | |
| Financing expenses | (5) | (18) | 1 | (22) | |
| Share in profit of associated companies | - | 21 | - | 21 | |
| Profit/(loss) before taxes | 12 | (11) | 6 | 7 | |
| Income tax (expense)/benefits | (6) | 6 | (1) | (1) | |
| Profit/(loss) for the period | 6 | (5) | 5 | 6 |
| For the three months ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM | Other | Consolidated Results | |
| \$ millions | |||||
| Revenue | 146 | 35 | - | - | 181 |
| Depreciation and amortization | (17) | (7) | - | - | (24) |
| Financing income | 1 | 1 | - | 6 | 8 |
| Financing expenses | (17) | (8) | - | (6) | (31) |
| Gains related to ZIM | - | - | 111 | - | 111 |
| Share in profit of associated companies | - | 4 | - | - | 23 |
| (Loss)/profit before taxes | (1) | (6) | 111 | 3 | 107 |
| Income tax (expense)/ benefits | (1) | 1 | - | - | (8) |
| (Loss)/profit for the period | (2) | (5) | 111 | 3 | 107 |

Summary of OPC consolidated financial information
| For the six months ended June 30, |
For the three months ended June 30, |
||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||
| \$ millions | \$ millions | ||||
| Revenue | 378 | 355 | 196 | 181 | |
| Cost of sales (excluding depreciation and amortization) | (289) | (247) | (150) | (129) | |
| Depreciation and amortization | (33) | (42) | (16) | (24) | |
| Gross profit | 56 | 66 | 30 | 28 | |
| Selling, general and administrative expenses | (43) | (38) | (28) | (17) | |
| Other expenses, net | (5) | (7) | (2) | (1) | |
| Operating profit | 8 | 21 | - | 12 | |
| Financing expenses | (39) | (47) | (23) | (25) | |
| Financing income | 6 | 6 | 3 | 2 | |
| Financing expenses, net | (33) | (41) | (20) | (23) | |
| Share in profit of associated companies, net | 59 | 23 | 21 | 4 | |
| Profit/(loss) before income taxes | 34 | 4 | 1 | (7) | |
| Income tax expense | (7) | (7) | - | - | |
| Profit/(loss) for the period | 27 | 3 | 1 | (7) | |
| Attributable to: | |||||
| Equity holders of the company | 20 | 1 | 1 | (4) | |
| Non-controlling interest | 7 | (4) | - | (3) | |
| Profit/(loss) for the period | 27 | (3) | 1 | (7) | |
| For the six months ended June 30, |
For the three months ended June 30, |
||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||
| \$ millions | \$ millions | ||||
| Cash flows provided by operating activities | 78 | 89 | 13 | 17 | |
| Cash flows used in investing activities | (140) | (139) | (53) | (71) | |
| Cash flows provided by financing activities | 250 | (34) | 262 | 21 | |
| Increase/(decrease) in cash and cash equivalents | 188 | (84) | 222 | (33) | |
| Cash and cash equivalents at beginning of the year | 264 | 278 | 264 | 278 | |
| Effect of exchange rate fluctuations on balances of cash and cash equivalents | 18 | (1) | 22 | (2) | |
| Cash and cash equivalents at end of the period | 470 | 192 | 470 | 192 |
| As at | ||
|---|---|---|
| June 30, | December 31, | |
| 2025 | 2024 | |
| \$ millions | ||
| Total financial liabilities1 | 1,403 | 1,267 |
| Total monetary assets2 | 487 | 280 |
| Investment in associated companies | 1,568 | 1,459 |
| Total equity attributable to the owners | 1,564 | 1,303 |
| Total assets | 3,772 | 3,309 |
Including loans from banks and others and debentures
Including cash and cash equivalents, term deposits and restricted cash
Definition of OPC's EBITDA and Adjusted EBITDA including proportionate share of associated companies and non-IFRS reconciliation
This press release presents OPC's Adjusted EBITDA including proportionate share of associated companies, which is a non-IFRS financial measure.
OPC's EBITDA is defined for each period as net profit/(loss) before depreciation and amortization, financing expenses, net, and income tax expense. OPC's Adjusted EBITDA, including proportionate share of associated companies, is defined as EBITDA as further adjusted for expenses not in the ordinary course of business and/or of a non-recurring nature and share of depreciation and amortization, financing expenses and income tax expenses (if any) of associated companies. EBITDA and Adjusted EBITDA including proportionate share of associated companies are not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. EBITDA and Adjusted EBITDA including proportionate share of associated companies are not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of EBITDA and Adjusted EBITDA including proportionate share of associated companies as measures of OPC's profitability since it does not take into consideration certain costs and expenses that result from OPC's business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
OPC believes that the disclosure of EBITDA and Adjusted EBITDA including proportionate share of associated companies provides useful information to investors and financial analysts in their review of the company's, its subsidiaries', and its associated companies' operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.
Set forth below is a reconciliation of OPC's net profit to EBITDA and Adjusted EBITDA including proportionate share of associated companies for the periods presented. Other companies may calculate EBITDA and Adjusted EBITDA including proportionate share of associated companies differently, and therefore this presentation of EBITDA and Adjusted EBITDA including proportionate share of associated companies may not be comparable to other similarly titled measures used by other companies.
| For the three months ended June 30, |
|||
|---|---|---|---|
| 2025 | 2024 | ||
| \$ millions | |||
| Profit for the period | 1 | (7) | |
| Depreciation and amortization | 18 | 24 | |
| Financing expenses, net | 20 | 23 | |
| Income tax expense | - | - | |
| EBITDA | 39 | 40 | |
| Share of depreciation and amortization and financing expenses included within share of profit of associated | |||
| companies, net | 50 | 26 | |
| Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature | 1 | - | |
| Adjusted EBITDA including proportionate share of associated companies | 90 | 66 | |
Have a question? We'll get back to you promptly.